Observational Study of LUMRYZ in Narcolepsy

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

71 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-18

Study Completion Date

2025-10-28

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is an observational study of LUMRYZ prescribed in clinical practice. Patients are asked if they would be willing to complete questionnaires over a 4-month period after starting LUMRYZ. The questionnaires ask about narcolepsy symptoms, experience with LUMRYZ, and quality of life.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Extended-release Sodium Oxybate (Lumryz) in Spasmodic Dysphonia and Voice Tremor

NCT07041203

Spasmodic Dysphonia Laryngeal Dystonia Voice Tremor

NOT_YET_RECRUITING PHASE1

Investigation of Kinetic Oscillation Stimulation by the Chordate System S101 in the Treatment of Non Allergic Rhinitis

NCT03399721

Nasal Congestion Non-allergic Rhinitis

COMPLETED NA

Clinical Outcomes in Narcolepsy and Cataplexy: An Evaluation of Reboxetine Treatment (CONCERT)

NCT03881852

Narcolepsy Cataplexy Narcolepsy Excessive Sleepiness

COMPLETED PHASE2

Validating and AI Software for Assessment of Children With Ear Concerns

NCT07243093

Otalgia Otitis Media Otitis Media Effusion

NOT_YET_RECRUITING

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

NCT02038972

Sensorineural Hearing Loss

COMPLETED PHASE1/PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Narcolepsy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients Starting LUMRYZ

The cohort is comprised of patients prescribed LUMRYZ in clinical practice. All dosing decisions are made by the clinician.

LUMRYZ

Intervention Type DRUG

Prescribed for narcolepsy in accordance with product label.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

LUMRYZ

Prescribed for narcolepsy in accordance with product label.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults with narcolepsy
* Oxybate naive or prior treatment with twice-nightly oxybate
* Access to smart phone, tablet or laptop with reliable internet connection
* Able to read/understand English
* Written informed consent and ability to comply with schedule

Exclusion Criteria

* Already using LUMRYZ
* Clinical or mental health condition excluded by LUMRYZ label
* Any other condition/situation that would adversely impact participation

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No